Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
about
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophiliaPiperacillin/tazobactam-induced paresthesiae.Adaptive Laboratory Evolution of Antibiotic Resistance Using Different Selection Regimes Lead to Similar Phenotypes and Genotypes.Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins.Cross-Canada survey of resistance of 2747 aerobic blood culture isolates to piperacillin/tazobactam and other antibiotics.Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model.Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections.
P2860
Q24533461-F381E046-7A6D-4960-B76B-45DC03B13AC9Q33370885-24EC367E-E17E-4789-8A01-8DE669829090Q33659055-CA2030D3-3654-4FF6-8D77-140E2E6EE8A6Q33701687-49D5E69F-C8BF-4B28-AF06-A71E3D9EA190Q34824085-611D7D65-723B-4C01-9DC2-45A155963399Q35114789-8B11CDC2-04DA-43A5-B7F7-40143867F23AQ35650111-3B77E998-CCB5-42E5-9F07-81713CD0803CQ35891315-12009F67-5792-4D79-A6DD-8AFFCA6E1316Q36839703-C517560A-3197-4364-A579-1A5C16BF2E87Q38325959-A5BCD93D-DCD8-4F62-A113-519D8A95E9F1Q39867395-42F05CDF-C124-43BA-9BD0-E1D2C3C0DC58Q43085417-2CA656A9-4EB8-43D6-87BE-FF0CA9E55323Q46588566-15DA9A15-CC4A-44C5-9ABE-F14F105D5A22Q53989640-C826EFA5-9AAC-4DED-90A2-D3F725D87DC5
P2860
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Piperacillin/tazobactam. A rev ...... ies and therapeutic potential.
@en
type
label
Piperacillin/tazobactam. A rev ...... ies and therapeutic potential.
@en
prefLabel
Piperacillin/tazobactam. A rev ...... ies and therapeutic potential.
@en
P1433
P1476
Piperacillin/tazobactam. A rev ...... ies and therapeutic potential.
@en
P2093
H M Bryson
P304
P356
10.2165/00003495-199447030-00008
P577
1994-03-01T00:00:00Z
P6179
1004903342